Omidubicel-onlv Transplantation for Hematologic Malignancies: Results of a Multicenter Expanded Access Program.

Horwitz ME, Schiller GJ, Tsai SB, Rezvani AR, Maziarz RT, Goshen U, Levy S, Schwarzbach A, Mazor RD, Stiff PJ

Open source

DOI
10.1016/j.jtct.2025.04.005
Published
2025 Jul
Container
Transplantation and cellular therapy
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.jtct.2025.04.005,
  title = {Omidubicel-onlv Transplantation for Hematologic Malignancies: Results of a Multicenter Expanded Access Program.},
  author = {Horwitz ME and Schiller GJ and Tsai SB and Rezvani AR and Maziarz RT and Goshen U and Levy S and Schwarzbach A and Mazor RD and Stiff PJ},
  year = {2025},
  journal = {Transplantation and cellular therapy},
  doi = {10.1016/j.jtct.2025.04.005},
  url = {https://doi.org/10.1016/j.jtct.2025.04.005}
}

RIS

TY  - JOUR
TI  - Omidubicel-onlv Transplantation for Hematologic Malignancies: Results of a Multicenter Expanded Access Program.
AU  - Horwitz ME
AU  - Schiller GJ
AU  - Tsai SB
AU  - Rezvani AR
AU  - Maziarz RT
AU  - Goshen U
AU  - Levy S
AU  - Schwarzbach A
AU  - Mazor RD
AU  - Stiff PJ
PY  - 2025
JO  - Transplantation and cellular therapy
DO  - 10.1016/j.jtct.2025.04.005
UR  - https://doi.org/10.1016/j.jtct.2025.04.005
ER  - 

APA

ME, H., GJ, S., SB, T., AR, R., RT, M., U, G., S, L., A, S., RD, M., & PJ, S. (2025). Omidubicel-onlv Transplantation for Hematologic Malignancies: Results of a Multicenter Expanded Access Program.. Transplantation and cellular therapy. https://doi.org/10.1016/j.jtct.2025.04.005

Source records